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degranulation, and mediator release of
human MCs in vitro, and that topical
treatment with a 6% miltefosine solu-
tion may inhibit IgE-dependent human
MC activation in vivo. The in vitro MC-
stabilizing effect of miltefosine appears
not to be limited to IgE-dependent
activation nor to histamine release but
also comprises alternative IgE-indepen-
dent activation pathways and release of
cytokines. In addition, we provide
proof-of-concept that miltefosine also
inhibits IgE-dependent MC-mediated
inflammatory responses in vivo.
These results indicate that agents
with raft disrupting properties, such
as miltefosine, have the potential as
new therapeutics for the treatment of
MC-driven diseases and we suggest
that clinical studies should be under-
taken to confirm the efficacy of milte-
fosine and related substances on
MC-related effects. In addition, future
investigations will need to address
the complexity of cellular pathways
involved in their inhibition of MC
activation and mediator release. All
examinations were performed after in-
stitutional approval and in adherence
to the Declaration of Helsinki. All
volunteers gave their written informed
consent.
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TO THE EDITOR
Thymic stromal lymphopoietin (TSLP)
appears to be a master switch for
T helper (Th)2 allergic inflammation
such as atopic dermatitis (AD) and
asthma (Liu, 2006). TSLP expression is
increased in keratinocytes in skin le-
sions of patients with AD (Soumelis
et al., 2002), and various mouse models
have established a link between TSLP
expression and the pathogenesis of AD
(Li et al., 2005, 2006; Yoo et al., 2005).
Abbreviations: AD, atopic dermatitis; LN, lymph node; Th2, T helper 2; TSLP, thymic stromal
lymphopoietin; WT, wild-type
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Transgenic mice overexpressing TSLP
in keratinocytes have been shown to
develop a human AD-like syndrome
(Li et al., 2005; Yoo et al., 2005),
indicating that TSLP expression is
sufficient to initiate AD-like skin in-
flammatory responses. We have also
reported that topical application of
either active vitamin D3 or the low-
calcemic analogue MC903 (calcipo-
triol) triggers a mouse AD-like
syndrome, characterized by a red, scaly,
and lesioned skin, accompanied by an
epidermal hyperplasia and a dermal
infiltration of CD4þ lymphocytes, eo-
sinophils, dendritic cells, and mast
cells, as well as by an increase of Th2
cytokine in skin, and an elevated serum
IgE and blood eosinophilia (Li et al.,
2006). Importantly, we demonstrated
that MC903 treatment induced TSLP
expression in mouse keratinocytes and
that this induction was mediated through
keratinocytic vitamin D receptor, as
upon MC903 treatment, VDRep/ mice
in which vitamin D receptor was selec-
tively ablated in keratinocytes neither
expressed TSLP, nor developed an
AD-like syndrome (Li et al., 2006).
However, it has not yet been demon-
strated that TSLP expression in keratino-
cytes is necessary for the generation of
an AD-like phenotype. It is indeed
known that vitamin D3 has pleiotropic
actions (Lin and White, 2004), and it has
been shown that vitamin D3 can have a
direct effect on naive CD4þ T cells to
enhance the development of Th2 cells
(Boonstra et al., 2001), and also act
directly on antigen-presenting cells (such
as macrophages and dendritic cells) (Lin
and White, 2004).
With the aim of demonstrating the
indispensability of keratinocytic TSLP in
the generation of MC903-induced AD,
a loxP-flanked (‘‘floxed’’) TSLP mouse
line in which exons 2, 3, and 4 of both
alleles of the TSLP gene are floxed
(TSLPL2/L2 mice) was produced (Figure
1a; Supplementary Methods), and
crossed with K14-Cre transgenic mice
(Li et al., 2001) to obtain keratinocyte-
selective TSLP mutant mice (TSLPep/),
or with cytomegalovirus-Cre transgenic
mice (Dupe´ et al., 1997) to generate
germline null mutant mice (TSLP/).
Quantitative PCR analyses of L and L2
alleles (Supplementary Methods) of
various tissues from 6-week-old
TSLPep/ mice showed, as expected,
that the excision of TSLP selectively
occurred in the epidermis, as well as in
salivary gland, tongue, and thymus
(Figure 1b; data not shown). TSLP
RNA level was severely diminished in
TSLPep/ skin when compared to age-
and sex-matched control wild-type
(WT) littermate mice (Figure 2k).
Accordingly, when 6-week-old female
TSLPep/ and WT mice were daily
topically treated with MC903 on both
ears (2 nmol per ear) for 3 days, and
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Figure 1. Generation and characterization of TSLPep/ mice in which TSLP is selectively ablated in keratinocytes. (a) Schematic drawing of the TSLP
wild-type allele (þ ), the targeting construct (containing the FRT-flanked neomycin (Neo) resistance gene), the floxed (L2) allele after FLP-mediated excision of
Neo, and the excised (L) allele after Cre-mediated excision of exons 2–4. Red boxes stand for exons (E). LoxP and FRT sites are indicated. (b) L and L2 alleles
were quantified by PCR on DNA extracted from various tissues of a TSLPep/ (K14-Cretg/0/TSLPL2/L2) mouse. The L/L2 ratio shows that the excision occurred in
epidermis (Epi), as well as in salivary gland (Sa), thymus (Thy), and tongue (To), but not in dermis (Der), lymph node (LN), kidney (Ki), liver (Li), lung (Lu), or eye.
(c) Ears of control wild-type (WT) and TSLPep/ mice were topically treated with MC903 (2 nmol per ear) daily for 3 days, and sampled at day 4 (D4). Ear
sections were stained with an antibody against TSLP (upper and middle panels), or with IgG from goat serum as negative (Neg) control (lower panels). Yellow
corresponds to staining of TSLP antibody, whereas blue corresponds to DAPI staining of nuclei. White arrow points to one of the TSLP-stained cells in epidermis
of WTþMC903 mice, and white arrowheads point to autofluorescent erythrocytes. White dashed lines indicate the dermal/epidermal junction. Scale bar,
50mm. (d) Serum TSLP levels at D4 in WT and TSLPep/ mice.
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ears were sampled at day 4 (D4), TSLP
was detected by immunohistochemistry
in epidermal keratinocytes of MC903-
treated WT ears, whereas no signal
could be seen in MC903-treated
TSLPep/ ears (Figure 1c). Consistently,
MC903-treated WT mice exhibited a
high TSLP serum level (42500 pg/ml) at
D4 (Li et al., 2006), whereas in TSLPep/
mice, MC903 failed to induce serum
TSLP (o16 pg/ml; Figure 1d).
TSLPep/ pups grew normally and
did not exhibit any apparent abnorm-
alities with time (3–50 weeks), and
histological analyses in the skin did
not reveal any obvious differences
between WT and TSLPep/ mice (Fig-
ure 2b ; data not shown). MC903
(1 nmol per ear) was applied daily on
8-week-old WT or TSLPep/ ears for 15
days to generate the AD-like syndrome
(Li et al., 2006). At D16, ethanol (as
vehicle control) treatment had no effect
on WT and TSLPep/ ears (Figure 2a,
upper panel), whereas MC903-treated
WT ears were red, scaly, swollen,
lesioned, and crusted (Figure 2a, lower
WT+MC903 WT+MC903TSLPep–/– +MC903 TSLPep–/– +MC903
Figure 2. Induction of TSLP expression in keratinocytes is necessary for generating an AD-like syndrome upon application of the active vitamin D3
analogue MC903 on mouse skin. (a) Appearance and (b) hematoxylin/eosin-stained sections of ears sampled at day 16 (D16) from wild-type (WT) and
TSLPep/ mice, topically ear-treated with ethanol (EtOH, as vehicle control) or MC903 (1 nmol per ear) daily for 15 days. Arrows point to dermal/epidermal
junction. Scale bar, 50 mm. (c–g) Immunohistochemical (IHC) staining of CD3 (c), CD4 (d), CD11b (e), GR1 (f), and CD11c (g) on ear sections from MC903
topically treated WT (left panels) and TSLPep/ (right panels) mice at D16. White dashed lines indicate the dermal/epidermal junction. Yellow corresponds
to staining of antibodies, whereas blue corresponds to DAPI staining of nuclei. White arrows point to one of the specific antibody-stained cells in the dermis,
and white arrowheads to one of the specific antibody-stained cells in the epidermis. Scale bars, 50 mm. (h) Toluidine blue (TB)-stained sections. Red arrows
point to one of the mast cells with intense blue in the dermis. Scale bar, 50 mm. (i) Serum IgE levels of MC903-treated WT and TSLPep/ mice at D0, D8,
and D16. (j) Eosinophil counts in blood of MC903-treated WT and TSLPep/ mice at D0 and D16. (k, l) Cytokine and chemokine expression in ears (k)
and ear-draining lymph nodes (l) of EtOH or MC903-treated WT and TSLPep/ mice at D16. *Po0.05. Error bars indicate s.d.
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left panel). In contrast, MC903-treated
TSLPep/ ears appeared dry and scaly,
but were not red or inflamed, and no
lesion developed (Figure 2a, lower right
panel). Histologically, at D16, MC903-
treated WT skin exhibited an epidermal
hyperplasia and a heavy dermal cell
infiltrate (Figure 2b, lower left panel)
that included numerous eosinophils (as
shown by hematoxylin/eosin staining
(Figure 2b, inset), and by CD11b or
GR1 immunohistochemistry that stains
granulocytes), CD3þ T lymphocytes
mainly comprising CD4þ helper T cells,
CD11cþ dendritic cells, and mast cells
(toluidine blue staining) (Figure 2c–h;
Supplementary Methods), as previously
reported (Li et al., 2006). In contrast,
dermal infiltration was largely abrogated
in MC903-treated TSLPep/ ears, show-
ing only few eosinophils, CD4þ helper
T cells, dendritic cells, and mast cells
(Figure 2c–h). However, some epidermal
hyperplasia was observed (Figure 2b,
lower right panel), suggesting that
MC903 application could induce some
epidermal hyperplasia in a TSLP-inde-
pendent manner. A systemic increase in
serum IgE levels, which was lower in
TSLPep/ than in WT mice at D16, was
observed upon MC903 treatment (Figure
2i). Furthermore, an increase in eosino-
phil and lymphocyte counts was
observed in WT but not in TSLPep/
blood (Figure 2j; data not shown). Taken
together, these results indicated that
selective ablation of TSLP in epidermal
keratinocytes precludes the generation of
an AD-like syndrome upon MC903
topical application. Not unexpectedly,
similar observations were made with
TSLP germline mutants (TSLP/) and
with mutants in which TSLP was selec-
tively ablated in keratinocytes of adult
mice by using the tamoxifen-inducible
CreERT2 recombinase (Metzger et al.,
2003; data not shown).
To further characterize the involve-
ment of TSLP-dependent signaling in AD
generation, we next examined the pat-
tern of skin cytokine expression upon
MC903 treatment (Figure 2k; Supple-
mentary Methods). TSLP expression was
highly induced by MC903 treatment in
WT, but not in TSLPep/ skin. However,
a slight increase of TSLP in TSLPep/
skin was noted upon MC903 treatment,
most probably reflecting an induction of
TSLP by MC903 in nonkeratinocytic cells
(for example, mast cells and basophils
that also express TSLP; Soumelis and Liu,
2004; Sokol et al., 2008), as this increase
was not observed in TSLP/ null mutant
mice (Figure S1). Th2 cytokines (IL4,
IL13, IL10, IL6, and IL31) and eosinophil-
attractant chemokines (eotaxin-2 and
monocyte chemotactic protein-2) were
highly induced by MC903 in WT skin,
whereas this induction was much weaker
in MC903-treated TSLPep/ skin,
although not abolished, when compared
with vehicle (ethanol) treatment. To
examine whether this weak induction
could reflect a keratinocytic TSLP-inde-
pendent regulation, cytokine expression
was also analyzed in TSLP/ null
mutant skin (Figure S1). IL4, IL13,
IL31, and eotaxin-2 were not induced
in TSLP/ skin upon MC903 treatment,
indicating that the MC903-induced ex-
pression of these cytokines is fully
dependent on TSLP. In contrast, some
induction of IL10, IL6, and monocyte
chemotactic protein-2 was observed in
TSLP/ skin upon MC903 treatment,
suggesting that their overall induction
may be contributed by both TSLP-
dependent and -independent signaling.
On the other hand, upregulation of the
Th1 cytokine IFNg by MC903 similarly
occurred in WT and TSLPep/ skin,
indicating that its induction was inde-
pendent of TSLP.
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Figure 2. Continued.
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Cytokine expression was also ana-
lyzed in skin-draining lymph nodes (LN;
Figure 2l). Upon MC903 treatment, the
induction of Th2 cytokines (IL4, IL13,
IL10, IL6, and IL31) in WT LNs was not
observed in TSLPep/ LNs, indicating
that the MC903-triggered Th2 response
is abolished in TSLPep/ mice. No
change was seen for IFNg transcript
levels in WT or TSLPep/ LNs, from
either MC903- or ethanol-treated mice,
suggesting that MC903 application does
not involve a Th1 response in LNs.
In conclusion, we demonstrate un-
equivocally here that TSLP produced by
keratinocytes is absolutely required in
pathogenesis of AD triggered by topical
application of the vitamin D3 analogue
MC903. We also show that in this AD
model, induction of IL4, IL13, IL31, and
eotaxin-2 is fully TSLP dependent,
whereas that of IL6, IL10, and mono-
cyte chemotactic protein-2 is only
partially TSLP dependent, and that of
IFNg is TSLP independent. Finally, our
floxed TSLP mice will be helpful for
selective ablation of TSLP in other cell
types (Soumelis and Liu, 2004; Ziegler
and Liu, 2006; Holgate, 2007; Sokol
et al., 2008), and therefore to further
elucidate the physiological and patho-
logical function of this cytokine.
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SUPPLEMENTARY MATERIAL
Supplementary Methods
Figure S1. Comparison of cytokine and
chemokine expression in ears of ethanol or
MC903-treated wild-type (WT) and TSLP/ null
(germline mutation of TSLP) mice.
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Identification of XP Complementation Groups by
Recombinant Adenovirus Carrying DNA Repair Genes
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TO THE EDITOR
Individuals with xeroderma pigmento-
sum syndrome (XP) present an extre-
mely high sensitivity to sunlight, with
increased incidence of skin cancer
(especially in sun-exposed areas), when
compared to the normal population.
Some XP patients can also display
developmental complications and early
aging features.
A genetic defect in the nucleotide
excision repair pathway (NER) was
described as the molecular cause of
XP syndrome (Cleaver, 1968), and
somatic cell fusion accompanied by
Abbreviations: FHN, normal human fibroblast; NER, nucleotide excision repair; UDS, unscheduled DNA
synthesis; UV, ultraviolet; XP, xeroderma pigmentosum
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Recombinant Adenovirus to Identify XP Group
